StockWatch
·
HomeLiveReports
Agricultural Chemicals
AGM/EGMSep 4, 2026, 08:36 AM

Evogene Ltd. Holds Annual General Meeting, Approves Key Proposals

AI Summary

Evogene Ltd. filed a Form 6-K reporting on its annual general meeting of shareholders held on September 4, 2026. Key proposals, including 1(a) and 2-4, were approved by the shareholders. The composition of the board of directors was also confirmed following the meeting, with Ofer Haviv continuing as CEO and President.

Key Highlights

  • Evogene Ltd. held its annual general meeting of shareholders on September 4, 2026.
  • Shareholders approved Proposals Nos. 1(a) and 2-4.
  • The company's board of directors was confirmed, including Nir Nimrodi, Dr. Adrian Percy, Leon Y. Recanati, Dan Falk, Dr. Yael Margolin, Yoshinori Oikawa, and CEO Ofer Haviv.
View SEC Filing
EVGN
Agricultural Chemicals
Evogene Ltd.

Price Impact

More from EVGN

AGM/EGMJul 31, 4:08 PM

Evogene to Hold AGM on Sep 4; Board Election, Reverse Split on Agenda

Corporate GovernanceJul 17, 4:07 PM

Evogene faces activist demand to remove most board members

Business UpdateJun 16, 7:01 AM

Evogene Highlights AI-First Small Molecule Discovery Platform

More in AGM/EGM

VSAT1d ago, 5:27 PM

Viasat Inc. Elects Directors, Ratifies Auditor at Annual Meeting

KSCP1d ago, 5:06 PM

Knightscope Stockholders Approve Equity Plan Amendment, Elect Directors

INEO1d ago, 4:14 PM

INNEOVA Holdings Ltd Approves Share Consolidation at AGM; Re-elects Directors, Auditor Ratified